Skip to main content

Revolutionizing CRISPR Applications: High-Resolution sgRNA Analysis

Ensuring the quality of single guide RNA (sgRNA) is a major hurdle in CRISPR-Cas genome editing. Because these molecules are large (~100mer) and prone to complex secondary structures, separating them from nearly identical impurities requires precision.

Our latest application note demonstrates how the YMC Accura Triart Bio C18 column overcomes these challenges.

Key Breakthroughs in sgRNA Analysis:

►Exceptional Resolution: Successfully separates full-length sgRNA from closely related truncation impurities, such as n-1, n-2, and n-5 species.

►Bioinert Hardware: The specialized YMC Accura hardware minimizes non-specific adsorption to metal surfaces, ensuring high recovery and zero detectable carry-over.

►Widepore Efficiency: The 30 nm (300 Å) stationary phase is optimized for large oligonucleotides, providing superior mass transfer and peak shape.

►Sensitivity: Maintains consistent resolution and reliable performance even at low concentrations (down to 0.02 mg/mL).

Whether you are monitoring sequence fidelity or assessing the purity of modified sgRNA, this method provides a robust, reproducible solution for your CRISPR workflow.

Read the Application Note.

Posted on May 7, 2026.

Related Posts

September 4, 2026

YMC America Brings U.S.-Supplied ASME U-Stamped DAC Columns to Pharmaceutical Manufacturers

YMC America will be the First U.S.-Based Supplier of ASME U-Stamped DAC Columns. The company’s DAC columns support pharmaceutical and biopharmaceutical customers from process development through commercial production. Systems are used in laboratory, pilot, and production-scale chromatography applications, including purification processes for peptides, oligonucleotides, and small-molecule APIs.

September 10, 2026

Analytical Technologies for Therapeutic Peptides

Therapeutic peptides are an emerging class of active pharmaceutical ingredients that, together with other classes of bioproducts, have been attracting considerable attention due to their unique advantages. Their structure is based on well-defined amino acid sequences that may or may not contain structural modifications, resulting in molecules that generally range from 500 to 5000 Da. Currently, many examples can be used as medicines related to hormones, growth factors, neurotransmitters, among others.

September 9, 2026

Tecnologias Analíticas para Peptídeos Terapêuticos- Portuguese

Os peptídeos terapêuticos são uma classe emergente de insumos farmacêuticos ativos que, juntamente com outras classes de bioprodutos, vêm despertando grande interesse devido às suas vantagens únicas.

Designed and developed by